Evidence map›Paper›PMID 34113218›Full record

ArticleMolecular imaging2021

Early Changes in [

Yanina Dockx, Christel Vangestel, Tim Van den Wyngaert, Manon Huizing, Sven De Bruycker, Patrick Pauwels, Steven Staelens, Sigrid Stroobants

Open access · goldAbstract read
In one paragraph

Article in Molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yanina DockxMolecular Imaging Center Antwerp, University of Antwerp, Universiteitsplein 1, B-2610 Wilrijk, Belgium.ORCID 0000-0002-5832-4345
Christel VangestelNuclear Medicine, Antwerp University Hospital, Wilrijkstraat 10, B-2650 Edegem, Belgium.
Tim Van den WyngaertNuclear Medicine, Antwerp University Hospital, Wilrijkstraat 10, B-2650 Edegem, Belgium.
Manon HuizingMedical Oncology, Antwerp University Hospital, Wilrijkstraat 10, B-2650 Edegem, Belgium.
Sven De BruyckerMolecular Imaging Center Antwerp, University of Antwerp, Universiteitsplein 1, B-2610 Wilrijk, Belgium.ORCID 0000-0002-7560-5130
Patrick PauwelsAnatomical Pathology, Antwerp University Hospital, Wilrijkstraat 10, B-2650 Edegem, Belgium.
Steven StaelensMolecular Imaging Center Antwerp, University of Antwerp, Universiteitsplein 1, B-2610 Wilrijk, Belgium.
Sigrid StroobantsMolecular Imaging Center Antwerp, University of Antwerp, Universiteitsplein 1, B-2610 Wilrijk, Belgium.ORCID 0000-0002-6450-9944
Antwerp University Hospital · BEUniversity of Antwerp · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the potential use of [

Indexed as

NeoplasmsPharmaceutical PreparationsAnimalsFluorodeoxyglucose F18HeterograftsMiceMice, NudePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesFluorodeoxyglucose F18Pharmaceutical PreparationsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine Kinases

Identifiers

PMID34113218
PMCPMC8169268
OpenAlexW3165274020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.